GAZYVA
GAZYVA
Approved
DIN Number
02434806
Drug Class
Human
Market Date
Nov 28, 2014
Company
HC
Hoffmann-La Roche Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02434806
AIG Number0156270001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L01FA03 OBINUTUZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
OBINUTUZUMABActive
Strength: 25 MG / ML
Monograph: OBINUTUZUMAB